Alkermes hired Mark Stejbach as its first chief commercial officer. Stejbach will oversee the biotech firm's commercial activities, including marketing alcohol-addiction drug Vivitrol and, potentially, several pipeline projects. Stejbach recently held the same post at Tenjion, which focuses on regenerative medicine. He also served as Merck's VP of managed care marketing from 2005 to 2008.
Havas Worldwide Health's Euro RSCG Life UK made three senior appointments to its London-based team, in addition to bringing nine new executives on board. The senior appointments are Dr. Vernon Baiton as medical director, Jenny Plant as client services director, and Paul Delboy as SVP, director of operations Europe for Havas Worldwide Health. Baiton comes to Euro from Sudler & Hennessey, where he served as UK medical director for its medical communications business unit. Plant, who will oversee all account teams, has held similar roles at Publicis Life Brands and S&H. Delboy will oversee all day-to-day operations and production services for the two Havas agency networks Euro RSCG Life and Health 4 Brands.